TY - JOUR
T1 - Deletions of SCN2A and SCN3A genes in a patient with West syndrome and autistic spectrum disorder
AU - Chong, Pin Fee
AU - Saitsu, Hirotomo
AU - Sakai, Yasunari
AU - Imagi, Toru
AU - Nakamura, Ryoko
AU - Matsukura, Masaru
AU - Matsumoto, Naomichi
AU - Kira, Ryutaro
N1 - Funding Information:
We thank the patient and his family for their participation in this study. We also thank Nobuko Watanabe and Mai Sato for their technical assistance. This work is supported in part by a grant for Research on Measures for Intractable Diseases ( 14525125 ); a grant for Comprehensive Research on Disability Health and Welfare ( 13802019 ); the Strategic Research Program for Brain Science (SRPBS) ( 11105137 ) and Practical Research Project for Rare/Intractable Diseases ( 27280301 ), and a grant for Initiative on Rare and Undiagnosed Diseases in Pediatrics (IRUD-P) ( 15gk0110012h0101 ) from Japan Agency for Medical Research and Development ; a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle, 24118007 ) from the Ministry of Education, Culture, Sports, Science and Technology of Japan ; Grants-in-Aid for Scientific Research (B) ( 25293085 ) and (A) ( 13313587 ), Challenging Exploratory Research ( 26670505 ) from the Japan Society for the Promotion of Science ; the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems ( 11105305 ) from the Japan Science and Technology Agency ; and the Takeda Science Foundation .
Publisher Copyright:
© 2018 British Epilepsy Association
PY - 2018/8
Y1 - 2018/8
N2 - SCN2A encodes the alpha-subunit of voltage-gated sodium channel, Nav1.2, which is highly expressed at an early stage of the postnatal brain. Genetic studies revealed that de novo heterozygous mutations of SCN2A caused severe developmental disorders in childhood, such as autism and epileptic encephalopathy. However, few reports have demonstrated the cases carrying segmental deletions at the SCN2A locus for those with epileptic disorders. In this study, we report a 1.8-year-old boy, who presented with West syndrome in infancy and developed the sequelae of psychomotor delay and autism. Since whole-exome sequencing did not detect pathogenic mutations, we extensively searched for microdeletions and duplications by applying the eXome Hidden Markov Model (XHMM) for read depths of sequenced intervals. Using this approach, we identified a de novo deletion spanning the 1.1-Mb region of chromosome 2q24.3. We found that the deleted interval included the SCN2A and SCN3A loci. These data validate the utility of XHMM and support that SCN2A is involved in the pathogenic processes underlying epileptic encephalopathy in childhood.
AB - SCN2A encodes the alpha-subunit of voltage-gated sodium channel, Nav1.2, which is highly expressed at an early stage of the postnatal brain. Genetic studies revealed that de novo heterozygous mutations of SCN2A caused severe developmental disorders in childhood, such as autism and epileptic encephalopathy. However, few reports have demonstrated the cases carrying segmental deletions at the SCN2A locus for those with epileptic disorders. In this study, we report a 1.8-year-old boy, who presented with West syndrome in infancy and developed the sequelae of psychomotor delay and autism. Since whole-exome sequencing did not detect pathogenic mutations, we extensively searched for microdeletions and duplications by applying the eXome Hidden Markov Model (XHMM) for read depths of sequenced intervals. Using this approach, we identified a de novo deletion spanning the 1.1-Mb region of chromosome 2q24.3. We found that the deleted interval included the SCN2A and SCN3A loci. These data validate the utility of XHMM and support that SCN2A is involved in the pathogenic processes underlying epileptic encephalopathy in childhood.
UR - http://www.scopus.com/inward/record.url?scp=85048815781&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048815781&partnerID=8YFLogxK
U2 - 10.1016/j.seizure.2018.06.012
DO - 10.1016/j.seizure.2018.06.012
M3 - Article
C2 - 29929112
AN - SCOPUS:85048815781
SN - 1059-1311
VL - 60
SP - 91
EP - 93
JO - Seizure
JF - Seizure
ER -